Publications by authors named "Anna M Miscio"

Claim this Profile
R
Real-World Insights into the Effectiveness and Tolerability of OnabotulinumtoxinA in Chronic Migraine: A Long-Term Evaluation of up to 11 Years.
Antonio Santoro, Andrea Fontana, Massimiliano Copetti, Anna Maria Miscio, Giuseppe d'Orsi

Toxins (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors.
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio

Int J Environ Res Public Health· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients.
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro

Pain Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro

Pain Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy.
Antonio Santoro, Massimiliano Copetti, Anna M Miscio, Maurizio A Leone, Andrea Fontana

Neurol Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application.
Antonio Santoro, Marianna Delussi, Maurizio Leone, Anna Maria Miscio, Laura De Rocco

Toxins (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
Antonio Santoro, Andrea Fontana, Anna M Miscio, Michele M Zarrelli, Massimiliano Copetti

Neurol Sci· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis